Kenneth J. Zuerblis, Director at STEMLINE THERAPEUTICS INC (STML), bought 1,000 shares at $11.14 ($11K) on 2014-09-02, disclosed to the SEC on 2014-09-04.
Open-market purchase of $11k STML by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| SVNT | BUY | 2011-09-16 | $20K | — | Filing → |